SE8503762L - Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa - Google Patents

Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa

Info

Publication number
SE8503762L
SE8503762L SE8503762A SE8503762A SE8503762L SE 8503762 L SE8503762 L SE 8503762L SE 8503762 A SE8503762 A SE 8503762A SE 8503762 A SE8503762 A SE 8503762A SE 8503762 L SE8503762 L SE 8503762L
Authority
SE
Sweden
Prior art keywords
analgesic
xantines
analgetic
procedure
compositions containing
Prior art date
Application number
SE8503762A
Other languages
English (en)
Other versions
SE8503762D0 (sv
SE469874B (sv
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of SE8503762L publication Critical patent/SE8503762L/sv
Publication of SE8503762D0 publication Critical patent/SE8503762D0/sv
Publication of SE469874B publication Critical patent/SE469874B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8503762A 1983-12-12 1985-08-09 Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och ett eller flera analgetiska medel eller xantiner och ett anti-inflammatoriskt medel SE469874B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/560,576 US4558051A (en) 1983-10-11 1983-12-12 Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Publications (3)

Publication Number Publication Date
SE8503762L true SE8503762L (sv) 1985-08-09
SE8503762D0 SE8503762D0 (sv) 1985-08-09
SE469874B SE469874B (sv) 1993-10-04

Family

ID=24238396

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503762A SE469874B (sv) 1983-12-12 1985-08-09 Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och ett eller flera analgetiska medel eller xantiner och ett anti-inflammatoriskt medel

Country Status (15)

Country Link
US (1) US4558051A (sv)
EP (1) EP0165308B1 (sv)
JP (1) JPS61500665A (sv)
AT (1) AT389997B (sv)
AU (1) AU574419B2 (sv)
CA (1) CA1246453A (sv)
CH (1) CH669730A5 (sv)
DE (1) DE3490583T1 (sv)
GB (1) GB2161076B (sv)
IE (1) IE58158B1 (sv)
IT (1) IT1177389B (sv)
NL (1) NL8420316A (sv)
SE (1) SE469874B (sv)
WO (1) WO1985002540A1 (sv)
ZA (1) ZA849675B (sv)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them
CH669523A5 (sv) * 1986-06-25 1989-03-31 Mepha Ag
DE3779374D1 (en) * 1986-08-28 1992-07-02 Sandoz Ag Xanthinderivate.
CH670090A5 (sv) * 1986-10-27 1989-05-12 Nestle Sa
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
ES2039646T3 (es) * 1987-11-13 1993-10-01 Glaxo Group Limited Derivados de fenetanolamina.
US4883818A (en) * 1987-11-17 1989-11-28 Analgesic Associates Onset-hastened/enhanced analgesia
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
JPH06500784A (ja) * 1990-09-11 1994-01-27 リチャードソン、ビックス、インコーポレーテッド 改善された鎮痛効果を与えるための方法
JPH08501796A (ja) * 1992-09-29 1996-02-27 メルク エンド カンパニー インコーポレーテッド イブプロフェン−カフェイン配合物
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1404332A1 (en) 2001-07-06 2004-04-07 Penwest Pharmaceuticals Company Methods of making sustained release formulations of oxymorphone related applications
BR0205721A (pt) 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
CA2466477C (en) 2001-11-09 2012-10-02 Rao Kalla A2b adenosine receptor antagonists
US7317017B2 (en) * 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
NZ553487A (en) * 2004-09-01 2010-09-30 Gilead Palo Alto Inc Method of wound healing using A2B adenosine receptor antagonists
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
BR112017021386A2 (pt) 2015-04-08 2018-07-03 Lewis And Clark Pharmaceuticals, Inc. carbamatos de alquinila com xantina substituída/carbamatos reversos como antagonistas de a2b.
CN109912598B (zh) * 2019-03-27 2022-09-13 四川大学华西医院 防治炎症反应的核苷类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
AU532600B2 (en) * 1977-04-02 1983-10-06 Hoechst A.G. Alkenyl xanthines and pharmaceutical compositions
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
FR2530469A1 (fr) * 1982-07-22 1984-01-27 Richardson Vicks Inc Composition analgesique et anti-inflammatoire contenant de la cafeine
US4479956A (en) * 1983-04-26 1984-10-30 Analgeic Associates Analgesic compositions comprising propiram and methods of using same

Also Published As

Publication number Publication date
IT1177389B (it) 1987-08-26
ZA849675B (en) 1985-07-31
EP0165308B1 (en) 1989-03-22
AT389997B (de) 1990-02-26
AU574419B2 (en) 1988-07-07
ATA905384A (de) 1989-08-15
JPS61500665A (ja) 1986-04-10
GB2161076B (en) 1988-03-30
CH669730A5 (sv) 1989-04-14
GB8519256D0 (en) 1985-09-04
EP0165308A1 (en) 1985-12-27
US4558051A (en) 1985-12-10
SE8503762D0 (sv) 1985-08-09
EP0165308A4 (en) 1986-05-16
IE843166L (en) 1985-06-12
CA1246453A (en) 1988-12-13
IT8424009A1 (it) 1986-06-12
SE469874B (sv) 1993-10-04
WO1985002540A1 (en) 1985-06-20
GB2161076A (en) 1986-01-08
IE58158B1 (en) 1993-07-28
AU3747485A (en) 1985-06-26
NL8420316A (nl) 1985-11-01
DE3490583T1 (de) 1986-04-03
IT8424009A0 (it) 1984-12-12

Similar Documents

Publication Publication Date Title
SE8503762D0 (sv) Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa
IT1206501B (it) Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
ES548168A0 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
MX9204786A (es) Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene.
SE8401538D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
MX9200324A (es) Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene.
SE8401537D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ATE59286T1 (de) Pharmazeutische mixtur.
FI893643A0 (fi) Farmaceutiska kompositioner.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE3784595D1 (de) Arzneimittel gegen feste tumoren.
DE3869806D1 (de) Zusammensetzung gegen leberkrankheiten.
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
MX9200443A (es) Hidrato de 6-ciclohexil-2'-o-metil-adenosina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
FI903653A0 (fi) Lokalt administrerbar farmaceutisk komposition.
IT8619751A0 (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione.
MX9203241A (es) Derivados de indol y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8503762-0

Format of ref document f/p: F

NUG Patent has lapsed
NUG Patent has lapsed